Emergent BioSolutions
EBS
#6684
Rank
โ‚ฌ0.57 B
Marketcap
10,71ย โ‚ฌ
Share price
0.72%
Change (1 day)
32.35%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): โ‚ฌ0.14 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are โ‚ฌ0.75 Billion. In 2024 the company made an earning of -โ‚ฌ60.99 Million, an increase over its 2023 earnings that were of -โ‚ฌ0.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.14 B-341.4%
2024 -โ‚ฌ60.99 Million-88.82%
2023 -โ‚ฌ0.55 Billion242.73%
2022 -โ‚ฌ0.16 Billion-153.8%
2021 โ‚ฌ0.29 B-20.43%
2020 โ‚ฌ0.37 B278.02%
2019 โ‚ฌ98.39 M27.11%
2018 โ‚ฌ77.4 M-27.12%
2017 โ‚ฌ0.10 B17.21%
2016 โ‚ฌ90.61 M0.45%
2015 โ‚ฌ90.21 M73.51%
2014 โ‚ฌ51.99 M41.36%
2013 โ‚ฌ36.78 M35.2%
2012 โ‚ฌ27.2 M0.4%
2011 โ‚ฌ27.09 M-56.46%
2010 โ‚ฌ62.23 M76.73%
2009 โ‚ฌ35.21 M32.94%
2008 โ‚ฌ26.49 M-5.62%
2007 โ‚ฌ28.06 M
2005 โ‚ฌ40.63 M269.89%
2004 โ‚ฌ10.98 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
โ‚ฌ19.58 B 13,868.54%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚ฌ76.58 M-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ7.90 B 5,539.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-โ‚ฌ0.22 Billion-255.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.05 B 7,069.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.50 B 971.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
-โ‚ฌ10.5 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA